Dominican citizen extradited to U.S. for drug trafficking through sham internet pharmacy
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Dominican citizen extradited to U.S. for drug trafficking through sham internet pharmacy

Dominican citizen extradited to U.S. for drug trafficking through sham internet pharmacy

September 02, 2020
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

New York, NY – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division, Susan A. Gibson, Acting U. S. Attorney for the Southern District of New York, Audrey Strauss, and the Inspector in Charge of the New Jersey Office of the Unites States Postal Inspection Service (USPIS), James Buthorn, announced today that Jose Francisco Guzman-Cabrera, a citizen of the Dominican Republic, was extradited yesterday from the Dominican Republic.

Guzman-Cabrera is charged with conspiracy to distribute controlled substances, including oxycodone, hydrocodone, the fentanyl analogue p-fluoroisobutyryl fentanyl, and the synthetic opioid U-47700, distribution of controlled substances over the Internet, and conspiracy to commit money laundering, in connection with a large-scale drug distribution operation  purporting to be an online pharmacy.  Guzman-Cabrera was arrested on July 3, 2020, in the Dominican Republic, and was presented today before U.S. Magistrate Judge James L. Cott.

DEA Special Agent in Charge Susan A. Gibson said:  “This investigation reinforces the dangers of purchasing narcotics through the internet. Mr. Guzman-Cabrera may have felt he was safe allegedly operating his drug trafficking organization from a foreign country, but great investigative work led to his arrest and extradition to the United States to face justice.

Acting U.S. Attorney Audrey Strauss said:  “As alleged, Jose Francisco Guzman-Cabrera was the kingpin of a drug trafficking organization that distributed dangerous opioids to individuals throughout the United States through a website purporting to be an online pharmacy. Thanks to the outstanding investigative work of the DEA and USPIS, Guzman-Cabrera is now in United States custody and facing prosecution in this District.

USPIS Inspector in Charge James Buthorn:  “As alleged, Guzman-Cabrera put citizens across the United States in harm’s way through his criminal syndicate, intentionally disregarding people’s safety.  No border will stop the United States Postal Inspection Service from bringing alleged criminals like Guzman-Cabrera to justice. We are proud of our partnerships both domestic and international, as well as our technological and analytical advancements in the recent years that are bringing positive results, making cases like this possible. Illicit narcotics traffickers, utilizing the open web or dark web, should know we are coming for you. I would also like to stress to the public the need to research your online pharmaceutical vendors, ensuring the medicines you order are safe. I commend the agents and inspectors on the successful outcome of this case.

Law enforcement agents began investigating an online pharmacy website (the “Pharmacy Website”) following an overdose death of a victim in Boise, Idaho, on or about March 17, 2017, whose death was caused by elevated levels of multiple prescription opioids as well as fentanyl. The victim’s computer showed that he had repeatedly ordered painkillers from the Pharmacy Website, paying thousands of dollars for these drugs. The subsequent investigation revealed that the Pharmacy Website was selling pills to customers located throughout the United States, and that Guzman-Cabrera led the drug trafficking organization that operated the Pharmacy Website. In the course of the investigation, undercover law enforcement agents conducted multiple purchases of controlled substances from the Pharmacy Website. The substances purchased by undercover law enforcement agents included oxycodone and hydrocodone.

The investigation has revealed that in some cases, customers purchased what they believed to be prescription drugs such as alprazolam or oxycodone from the Pharmacy Website, but instead received pills containing other substances. In 2018, law enforcement agents searched a residence in New Jersey that the Pharmacy Website used as a distribution center, and seized approximately 100,000 pills, including pills containing the fentanyl analogue p-fluoroisobutyryl fentanyl and pills U-47700, both of which are powerful synthetic opioids that have no recognized medical use in the United States.

Guzman-Cabrera, who was based in the Dominican Republic, coordinated the purchase of pills and tablets from sources overseas, and shipped these drugs to co-conspirators who operated drug distribution centers located in the United States. After customers placed orders for drugs on the Pharmacy Website, Guzman-Cabrera directed his co-conspirators to mail the drugs to these customers.  The drug trafficking organization then sent the proceeds from the sales, totaling millions of dollars, from the United States to the Dominican Republic through a variety of means, including money remitters, money couriers, and wire transfers between United States and Dominican Republic-based shell company bank accounts.

Ms. Strauss praised the outstanding investigative work of the DEA’s New Jersey Division, its Boise Division, and its Santo Domingo Country Office, and the USPIS.  She also thanked the Dominican Government’s National Directorate for Drug Control (DNCD) and the United States Marshals Service for their assistance in the case, as well as the U.S. Department of Justice’s Office of International Affairs of the Department’s Criminal Division for its significant assistance in securing the defendant’s extradition from the Dominican Republic.

###

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Cheryl Ortiz, Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español